Overall Survival in Advanced Stage Mantle Cell Lymphoma after Early Autologous Stem Cell Transplantation with Cisplatin, Etoposide ,Cytarabine and Melphalan (PEAM) As a Conditioning Regimen

被引：0
|
作者：
Franco, Daniel [1 ]
Tellez, Fernando [1 ]
Solis-Armenta, Ruben [1 ]
Leal Alanis, Araceli [1 ]
Cruz Castillo, Carlos [2 ]
Valero Saldana, Luis Manuel [1 ]
Acosta Maldonado, Brenda Lizeth [2 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
[2] Inst Natl Cancerol, Dept Hematol, Mexico City, DF, Mexico
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-191183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
    Visani, Giuseppe
    Malerba, Lara
    Stefani, Pietro Maria
    Capria, Saveria
    Galieni, Piero
    Gaudio, Francesco
    Specchia, Giorgina
    Meloni, Giovanna
    Gherlinzoni, Filippo
    Giardini, Claudio
    Falcioni, Sadia
    Cuberli, Francesca
    Gobbi, Marco
    Sarina, Barbara
    Santoro, Armando
    Ferrara, Felicetto
    Rocchi, Marco
    Ocio, Enrique M.
    Dolores Caballero, Maria
    Isidori, Alessandro
    BLOOD, 2011, 118 (12) : 3419 - 3425
  • [42] Busilvex in combination with etoposide and melphalan as conditioning regimen in autologous haematopoietic cell transplantation for lymphomas: efficacy and safety
    Sakellari, I.
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Iskas, M.
    Karypidis, K.
    Apostolou, C.
    Kaloyannidis, P.
    Batsis, I.
    Vadikoliou, C.
    Papaemmanouil, S.
    Palladas, P.
    Smias, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S450 - S450
  • [43] A Phase II Study Of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) As Conditioning Regimen Prior To Second Autologous Stem Cell Transplantation For Multiple Myeloma
    Wang, Tzu-Fei
    Fiala, Mark A.
    Wu, Ningying
    Fletcher, Theresa
    Abboud, Camille N.
    Cashen, Amanda F.
    Dipersio, John F.
    Uy, Geoffrey L.
    Westervelt, Peter
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    BLOOD, 2013, 122 (21)
  • [44] Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma after Autologous Stem Cell Transplantation
    Churnetski, Michael C.
    Switchenko, Jeffrey M.
    Goyal, Subir
    Shanmugasundaram, Krithika
    Calzada, Oscar
    Kolla, Bhaskar
    Bachanova, Veronika
    Gerson, James N.
    Barta, Stefan K.
    Maldonado, Edward
    Gordon, Max
    Danilov, Alexey V.
    Grover, Natalie S.
    Mathews, Stephanie
    Burkart, Madelyn
    Karmali, Reem
    Sawalha, Yazeed
    Hill, Brian T.
    Ghosh, Nilanjan
    Park, Steven I.
    Epperla, Narendranath
    Bond, David
    Badar, Talha
    Blum, Kristie A.
    Guo, Jin
    Martin, Peter
    Hamadani, Mehdi
    Fenske, Timothy S.
    Malecek, Mary
    Kahl, Brad S.
    Flowers, Christopher
    Cohen, Jonathon B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [45] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) is an effective high-dose chemotherapy consolidation regimen with autologous stem cell transplantation for patients with relapsed lymphoma in complete remission
    Pester, F.
    Klink, A.
    Scholl, S.
    Schilling, K.
    Muegge, L.
    Hoeffken, K.
    Sayer, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
  • [46] Autologous stem cell transplantation and Rituximab independently prolong response duration in advanced stage mantle cell lymphoma
    Hoster, E.
    Metzner, B.
    Pfreundschuh, M.
    Truemper, L.
    Hallek, M.
    Woermann, B.
    Duehrsen, U.
    Gisselbracht, C.
    Kluin-Nelemans, J. C.
    Van Hoof, A.
    Unterhalt, M.
    Hiddemann, W.
    Dreyling, M.
    ONKOLOGIE, 2010, 33 : 202 - 202
  • [47] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [48] Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma
    Kim, Ji-Won
    Lee, Hyun Jung
    Yi, Hyeon Gyu
    Kim, Byung-Su
    Bang, Soo-Mee
    Kim, Jin Seok
    Kim, Inho
    Yoon, Sung-Soo
    Lee, Jong Seok
    Kim, Chul Soo
    Park, Seonyang
    Kim, Byoung Kook
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (05) : 479 - 483
  • [49] Autologous Stem Cell Transplantation with Benda-Eam (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma
    Noesslinger, Thomas
    Panny, Michael
    Moestl, Michaela
    Koller, Elisabeth
    Keil, Felix
    BLOOD, 2016, 128 (22)
  • [50] Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma
    Noesslinger, Thomas
    Moestl, Michaela
    Tinchon, Christoph
    Koller, Elisabeth
    Linkesch, Werner
    Keil, Felix
    BLOOD, 2014, 124 (21)
12345